USPTO serial 86554584
GLYCOBIOME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- TMO LAW OFFICE 119 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with GLYCOBIOME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Cambridge, MA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
CHRISTINA M. LICURSI Wolf Greenfield & Sacks Pc600 Atlantic Ave Fl 23Boston, MA 02210-2206UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Genetic testing for scientific research purposes; Genetic testing for medical purposes; scientific and technological services, including acquisition, collection, analysis, compilation, electronic storage and distribution of metagenomic, metaproteomic, metatranscriptomic, and metabolomic data and related clinical, agricultural, and veterinary data for treatment and diagnostic purposes of humans, animals, and plants; development of computer databases and computer-readable programs, software, and scientific, analytical, and statistical tools for genomic, proteomic, transcriptomic, and metabolomic data, including patient clinical care information, veterinary care information, agricultural data, and medical research data; chemical, biochemical, and molecular diagnostic services, including chemical, immunological, and microbiological diagnostic service bacteriological, virological, fungal, protistal, and molecular diagnostic services; acquisition, collection, analysis, compilation, storage and distribution of biological samples, including microbial and tissue samples; diagnostic services for assessing health and determining treatment for metabolism, diabetes, obesity, cardiovascular disease, malnutrition, short bowel syndrome, frailty, autism, allergy, atopy, neurological disorders, chronic or acute inflammatory diseases, inflammatory bowel disease, diverticulitis, non-alcoholic steatohepatitis, infection, susceptibility to infection, colonization with drug-resistant organisms, fertility, aging, cancer, and autoimmune diseases; scientific research in the field of genetics, genetic engineering of microbes, and molecular testing; Research and development in the pharmaceutical and biotechnology fields; microbial and anti-microbial preparations and substances for pharmaceutical, veterinary and medical purposes for use in the treatment of metabolic disorders, diabetes, obesity, cardiovascular disease, malnutrition, short bowel syndrome, frailty, autism, allergy, atopy, neurological disorders, chronic or acute inflammatory diseases, inflammatory bowel disease, diverticulitis, non-alcoholic steatohepatitis, infection, susceptibility to infection, colonization with drug-resistant organisms, fertility, aging, cancer, and autoimmune diseases; dietary supplements, nutritional supplements, nutraceuticals, food supplements, beverages, nutritional food bars, and animal feed or feed supplements containing microorganisms for medical, veterinary, therapeutic or preventative purposes; therapeutic pharmaceuticals containing microorganisms for medical and veterinary use for the treatment or prevention of metabolic disorders, diabetes, obesity, cardiovascular disease, malnutrition, short bowel syndrome, frailty, autism, allergy, atopy, neurological disorders, chronic or acute inflammatory diseases, inflammatory bowel disease, diverticulitis, non-alcoholic steatohepatitis, infection, susceptibility to infection, colonization with drug-resistant organisms, fertility, aging, cancer, and autoimmune diseases; therapeutics, consumer products and articles, including moisturizers, creams, lotions, gels, toners, cleansers, bandages, and cosmetics, pharmaceutical, veterinary and medical preparations and substances diagnostic kits and diagnostic reagents; diagnostics and tools for medical purposes; instruments, supplies and disposables; computer databases and computer-readable programs, software, and scientific, analytical, and statistical tools | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 21, 2016 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 21, 2016 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 19, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 12, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 18, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |